Trexquant Investment »

Halozyme Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4M 120k 36.96
2023-09-30 $4.4M 115k 38.20
2023-06-30 $3.7M 101k 36.07
2023-03-31 $2.5M 65k 38.19
2022-03-31 $297k 7.5k 39.86
2021-12-31 $818k 20k 40.23
2021-09-30 $202k 5.0k 40.68
2021-06-30 $1.0M 23k 45.41
2021-03-31 $799k 19k 41.67
2020-09-30 $809k 31k 26.27
2020-06-30 $1.2M 43k 26.82
2020-03-31 $1.1M 60k 17.99
2019-12-31 $1.9M 108k 17.73
2018-09-30 $207k 11k 18.16
2018-03-31 $246k 13k 19.59
2017-09-30 $224k 13k 17.34
2017-03-31 $628k 49k 12.96
2016-12-31 $346k 35k 9.88
2016-06-30 $219k 25k 8.64
2016-03-31 $630k 67k 9.47
2015-12-31 $450k 26k 17.35
2015-09-30 $215k 16k 13.40
2015-03-31 $450k 32k 14.25
2014-12-31 $1.4M 140k 9.65